Calming Inflammation and Promoting Systemic Balance Inflammation is both a healing response and a silent antagonist when left unchecked
Of note, enzymatic GSH, GSSG, and GSH:GSSG measurements corresponded well with measures using a high-performance liquid chromatography system (Supplemental Figure 1)
We demonstrate that two peptide biased agonists (GEP44 and GEP12) of the GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors (GLP-1R, Y1-R, and Y2-R, respectively) elicit Y1-R antagonist-controlled, GLP-1R-dependent stimulation of insulin secretion in both rat and human pancreatic islets, thus revealing the counteracting effects of Y1-R and GLP-1R agonism
Clinicians should provide balanced, evidence-based information, acknowledging both the benefits of Ozempic in diabetes management and cardiovascular risk reduction, and the current uncertainty regarding long-term pancreatic safety
Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression
